Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2017 09:41 ET | Source: Cempra, Inc.

CORRECTING and REPLACING -- Cempra to Present at Upcoming Investor Conferences

CHAPEL HILL, N.C., Feb. 08, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Cempra, Inc. (Nasdaq:CEMP), the Leerink Partners conference should be noted...
February 08, 2017 07:30 ET | Source: Cempra, Inc.

Cempra to Present at Upcoming Investor Conferences

CHAPEL HILL, N.C., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
January 04, 2017 07:00 ET | Source: Cempra, Inc.

Cempra to Present at J.P. Morgan Healthcare Conference

CHAPEL HILL, N.C., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
December 05, 2016 08:00 ET | Source: Cempra, Inc.

Toyama Chemical (a Subsidiary of FUJIFILM Holdings Corporation) Begins Phase 3 Studies in Japan With Cempra’s Solithromycin

CHAPEL HILL, N.C., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
September 29, 2016 16:15 ET | Source: Cempra, Inc.

Cempra Announces Anti-NASH Effects of Solithromycin: Interim Results From Phase 2 Study

— Pre/post treatment biopsies confirm mean NAS reduction of 1.3 points after 90 days of treatment with solithromycin — — All six patients showed ALT reductions after 90 days of treatment with...
August 01, 2016 16:05 ET | Source: Cempra, Inc.

Cempra Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Current cash balance now expected to fund operations through 2017 Management to host webcast and conference call today at 4:30 p.m. EDTCHAPEL HILL, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) -- ...
August 01, 2016 07:30 ET | Source: Cempra, Inc.

Cempra Appoints John Bluth Executive Vice President, Investor Relations and Corporate Communications

CHAPEL HILL, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
June 28, 2016 07:00 ET | Source: Cempra, Inc.

Cempra Submits Marketing Authorization Application to EMA for Solithromycin in the Treatment of Community-Acquired Bacterial Pneumonia

CHAPEL HILL, N.C., June 28, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
June 16, 2016 07:30 ET | Source: Cempra, Inc.

Cempra to Host Analyst and Investor Day on June 23, 2016

CHAPEL HILL, N.C., June 16, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
May 25, 2016 16:30 ET | Source: Melinta Therapeutics, Inc.

Cempra Announces Successful Results in the Phase 2 Community Acquired Bacterial Pneumonia (CABP) Trial Conducted by Japanese Partner, Toyama Chemical (a subsidiary of FUJIFILM Holdings Corporation)

Solithromycin safety and efficacy further validated by Toyama (FUJIFILM) All efficacy outcome measures favored solithromycin Management to host Q&A webcast and conference call tomorrow at 8:00...

Next Page keyboard_arrow_right